The communication between chikungunya infection and the central nervous system
Microbial Pathogenesis · 2025
DOI: 10.1016/j.micpath.2025.107747 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Microbial Pathogenesis, 2025. Verfasst von Camila Neiva Porto Silva und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Therapeutic Innovation - Suelly Galdino (NUPIT-SG), Recife, Brazil. Hauptthemen laut MEDLINE: Chikungunya Fever, Chikungunya virus, Central Nervous System. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 102 Literaturangaben. Gefördert von: CNPq.
Abstract (Originalsprache)
Chikungunya virus (CHIKV) infection is primarily characterized by arthralgia, a persistent joint pain that can significantly impair quality of life. This symptom is linked to the inflammatory processes triggered by the virus. CHIKV infection progresses through acute, subacute, and chronic phases, with increased inflammation correlating to prolonged arthralgia and a poorer prognosis. Emerging evidence suggests that this inflammatory cascade may also play a role in neurological disorders. Neurological complications associated with CHIKV infection include encephalitis, optic neuritis, myeloradiculitis, and Guillain-Barré syndrome (GBS). When CHIKV accesses the central nervous system (CNS), it may do so either directly or through a "Trojan horse" mechanism, activating pro-inflammatory cytokine release and receptors such as HMGB1, P63, and STAR3, which amplify inflammation. This immune response in the CNS is similar to that seen in various neurological conditions, including autism, cerebral palsy, depression, Alzheimer's disease, and neuromyelitis optica. While research into CHIKV's systemic effects has grown, its impact on the CNS and potential role in neurodegenerative diseases remains underexplored. This review aims to fill this gap by examining the links between CHIKV infection and CNS involvement, underscoring the need for further investigation into its contribution to neurological outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Therapeutic Innovation - Suelly Galdino (NUPIT-SG), Recife, Brazil.
- Center for Therapeutic Innovation - Suelly Galdino (NUPIT-SG), Recife, Brazil; Department of Biochemistry, Federal University of Pernambuco, Recife, Brazil.
- Center for Therapeutic Innovation - Suelly Galdino (NUPIT-SG), Recife, Brazil; Department of Biochemistry, Federal University of Pernambuco, Recife, Brazil. Electronic address: michelle.rosa@ufpe.br.
Förderung
- CNPq
Zitieren
APA
Porto Silva, C. N., Crispim, J. G., Pereira, M. C., Galdino da Rocha Pitta, M., Barreto de Melo Rêgo, M. J., & Melgarejo da Rosa, M. (2025). The communication between chikungunya infection and the central nervous system. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2025.107747
Vancouver
Porto Silva CN, Crispim JG, Pereira MC, Galdino da Rocha Pitta M, Barreto de Melo Rêgo MJ, Melgarejo da Rosa M. The communication between chikungunya infection and the central nervous system. Microbial Pathogenesis. 2025. doi:10.1016/j.micpath.2025.107747
BibTeX
@article{PortoSilva2025,
author = {Porto Silva, Camila Neiva and Crispim, Joelson Germano and Pereira, Michelly Cristiny and Galdino da Rocha Pitta, Maira and Barreto de Melo Rêgo, Moacyr Jesus and Melgarejo da Rosa, Michelle},
title = {The communication between chikungunya infection and the central nervous system},
journal = {Microbial Pathogenesis},
year = {2025},
doi = {10.1016/j.micpath.2025.107747}
}
EUVIMED